Literature DB >> 18333204

The importance of complete excision of the caudate lobe in resection of hilar cholangiocarcinoma.

Sander Dinant1, Michael F Gerhards, Olivier R C Busch, Hugo Obertop, Dirk J Gouma, Thomas M Van Gulik.   

Abstract

BACKGROUND: The numbers of margin-negative resections and survival times have greatly improved because of a more aggressive surgical approach to resectable hilar cholangiocarcinoma (Klatskin tumour). It was shown initially by Japanese authors that complete resection of the caudate lobe together with partial hepatectomy leads to more margin-negative resections. However, this concept has not been unanimously taken up by Western authors. The aim of this study was to examine the role of complete caudate lobe resection in our series of resected hilar cholangiocarcinomas.
METHODS: Between January 1993 and January 2003, 54 patients underwent resection for Klatskin tumours. These patients were divided into two groups, according to the two 5-year periods in which they had been operated. In the first period, patients did not routinely undergo complete excision of the caudate lobe, whereas in the second period, partial liver resection was combined with complete excision of the caudate lobe in 15 patients. These two patient groups were evaluated with respect to postoperative morbidity and mortality, microscopic tumour margins and survival time.
RESULTS: Postoperative complications occurred in 59% of patients in total, while overall mortality was 11%. No difference was found in postoperative morbidity or mortality between the two periods. A significantly higher number of margin-negative resections was found in the second 5-year period, together with improved survival.
CONCLUSION: Concomitant complete excision of segment 1 for patients with hilar cholangiocarcinoma did not lead to increased morbidity or mortality. Therefore the addition of complete excision of segment 1 is a safe procedure contributing to a higher rate of R0 resections and improved survival.

Entities:  

Year:  2005        PMID: 18333204      PMCID: PMC2043102          DOI: 10.1080/13651820500372376

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  17 in total

1.  Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma.

Authors:  W R Jarnagin; Y Fong; R P DeMatteo; M Gonen; E C Burke; J Bodniewicz BS; M Youssef BA; D Klimstra; L H Blumgart
Journal:  Ann Surg       Date:  2001-10       Impact factor: 12.969

2.  Results of postoperative radiotherapy for resectable hilar cholangiocarcinoma.

Authors:  Michael F Gerhards; Thomas M van Gulik; Dioniso González González; Erik A J Rauws; Dirk J Gouma
Journal:  World J Surg       Date:  2003-02       Impact factor: 3.352

3.  Management strategies in resection for hilar cholangiocarcinoma.

Authors:  H Bismuth; R Nakache; T Diamond
Journal:  Ann Surg       Date:  1992-01       Impact factor: 12.969

4.  Complications of hepatectomy for hilar cholangiocarcinoma.

Authors:  M Nagino; J Kamiya; K Uesaka; T Sano; H Yamamoto; N Hayakawa; M Kanai; Y Nimura
Journal:  World J Surg       Date:  2001-10       Impact factor: 3.352

5.  Hepatic segmentectomy with caudate lobe resection for bile duct carcinoma of the hepatic hilus.

Authors:  Y Nimura; N Hayakawa; J Kamiya; S Kondo; S Shionoya
Journal:  World J Surg       Date:  1990 Jul-Aug       Impact factor: 3.352

6.  Prevention of implantation metastases after resection of proximal bile duct tumours with pre-operative low dose radiation therapy.

Authors:  M F Gerhards; D G Gonzalez; H ten Hoopen-Neumann; T M van Gulik; L T de Wit; D J Gouma
Journal:  Eur J Surg Oncol       Date:  2000-08       Impact factor: 4.424

7.  Diagnostic laparoscopy and laparoscopic ultrasound for staging of patients with malignant proximal bile duct obstruction.

Authors:  Esther H B M Tilleman; Steve M M de Castro; Olivier R C Busch; Willem A Bemelman; Thomas M van Gulik; Huug Obertop; Dirk J Gouma
Journal:  J Gastrointest Surg       Date:  2002 May-Jun       Impact factor: 3.452

8.  Results of surgical resection for patients with hilar bile duct cancer: application of extended hepatectomy after biliary drainage and hemihepatic portal vein embolization.

Authors:  Seiji Kawasaki; Hiroshi Imamura; Akira Kobayashi; Terumasa Noike; Shiro Miwa; Shin-ichi Miyagawa
Journal:  Ann Surg       Date:  2003-07       Impact factor: 12.969

9.  Surgical treatment of carcinoma of the hepatic duct confluence: analysis of 55 resected carcinomas.

Authors:  Y Ogura; R Mizumoto; M Tabata; S Matsuda; T Kusuda
Journal:  World J Surg       Date:  1993 Jan-Feb       Impact factor: 3.352

10.  Surgical management of proximal bile duct cancer: extended right lobe resection increases resectability and radicality.

Authors:  Peter Neuhaus; Sven Jonas; Utz Settmacher; Armin Thelen; Christoph Benckert; Enrique Lopez-Hänninen; Rainer E Hintze
Journal:  Langenbecks Arch Surg       Date:  2003-06-18       Impact factor: 3.445

View more
  22 in total

1.  Principles of surgical resection in hilar cholangiocarcinoma.

Authors:  Emilio Ramos
Journal:  World J Gastrointest Oncol       Date:  2013-07-15

2.  Defining Early Recurrence of Hilar Cholangiocarcinoma After Curative-intent Surgery: A Multi-institutional Study from the US Extrahepatic Biliary Malignancy Consortium.

Authors:  Xu-Feng Zhang; Eliza W Beal; Jeffery Chakedis; Qinyu Chen; Yi Lv; Cecilia G Ethun; Ahmed Salem; Sharon M Weber; Thuy Tran; George Poultsides; Andre Y Son; Ioannis Hatzaras; Linda Jin; Ryan C Fields; Stefan Buettner; Charles Scoggins; Robert C G Martin; Chelsea A Isom; Kamron Idrees; Harveshp D Mogal; Perry Shen; Shishir K Maithel; Carl R Schmidt; Timothy M Pawlik
Journal:  World J Surg       Date:  2018-09       Impact factor: 3.352

Review 3.  The Surgical Management of Klatskin Tumours: Has Anything Changed in the Last Decade?

Authors:  Neil Bhardwaj; Giuseppe Garcea; Ashley R Dennison; Guy J Maddern
Journal:  World J Surg       Date:  2015-11       Impact factor: 3.352

4.  Surgical outcomes and predicting factors of curative resection in patients with hilar cholangiocarcinoma: 10-year single-institution experience.

Authors:  Min Soo Cho; Sung Hoon Kim; Seung Woo Park; Jin Hong Lim; Gi Hong Choi; Joon Seong Park; Jae Bock Chung; Kyung Sik Kim
Journal:  J Gastrointest Surg       Date:  2012-07-14       Impact factor: 3.452

Review 5.  Curative-intent surgery for hilar cholangiocarcinoma: prognostic factors for clinical decision making.

Authors:  Irinel Popescu; Traian Dumitrascu
Journal:  Langenbecks Arch Surg       Date:  2014-05-20       Impact factor: 3.445

6.  [Surgical therapy of hilar cholangiocarcinoma].

Authors:  H Lang; G M Kaiser; T Zöpf; G C Sotiropoulos; A Frilling; M Malagó; C E Broelsch
Journal:  Chirurg       Date:  2006-04       Impact factor: 0.955

7.  Surgical strategy for bile duct cancer: Advances and current limitations.

Authors:  Nobuhisa Akamatsu; Yasuhiko Sugawara; Daijo Hashimoto
Journal:  World J Clin Oncol       Date:  2011-02-10

8.  Assessment of future remnant liver function using hepatobiliary scintigraphy in patients undergoing major liver resection.

Authors:  Wilmar de Graaf; Krijn P van Lienden; Sander Dinant; Joris J T H Roelofs; Olivier R C Busch; Dirk J Gouma; Roelof J Bennink; Thomas M van Gulik
Journal:  J Gastrointest Surg       Date:  2010-02       Impact factor: 3.452

Review 9.  Multimodal treatment strategies for advanced hilar cholangiocarcinoma.

Authors:  Matthew J Weiss; David Cosgrove; Joseph M Herman; Neda Rastegar; Ihab Kamel; Timothy M Pawlik
Journal:  Langenbecks Arch Surg       Date:  2014-06-25       Impact factor: 3.445

10.  Gemcitabine-based adjuvant chemotherapy improves survival after aggressive surgery for hilar cholangiocarcinoma.

Authors:  Yoshiaki Murakami; Kenichiro Uemura; Takeshi Sudo; Yasuo Hayashidani; Yasushi Hashimoto; Hiroaki Nakamura; Akira Nakashima; Taijiro Sueda
Journal:  J Gastrointest Surg       Date:  2009-05-07       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.